A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment
Clinical trial NCT04908189 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04908189
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2024-02-06
- Enrollment
- 729
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.